Bristol Myers Squibb Takes Serzone off the market on June 14 – AP Wed, 19 May 2004 The antidepressant Serzone, TAKEN OFF THE MARKET as of June 14 (for “business reasons” the company says). The drug was already taken off the market in Europe, Australia, New Zealand and Canada. In…
GlaxoSmithKline CEO: “We had to absorb a number of hits” Mon, 16 Feb 2004 Antidepressant drug safety issues are beginning to have a financial impact. Dow Jones reports: “GlaxoSmithKline PLC said its net income fell 6% in the fourth quarter, hurt by previously announced legal costs related to its anti-inflammatory…
For the Sake of Public Safety FDA & NIH Must Be Detatched from Drug Industry Tue, 21 Dec 2004 Daily front page reports about lethal drug effects leave no doubt that we are in the midst of a major health safety and credibility crisis, largely due to a drug development…
“Profits” / “Prophets”_NYT Editorial: Industry Distortion of the F.D.A. Wed, 8 Dec 2004 A White House transcript of President Bush’s speech at the Christmas tree lighting on Thursday: “We think of the patient hope of men and women across the centuries who listened to the words of the profits and…
FDA’s Lethal Weakness Requires More than Committees Sun, 7 Nov 2004 Bloomberg News reports that New York State Attorney General Eliot Spitzer requested information from Pfizer about the promotion of some of its drugs for unapproved uses – the recalled diabetes drug, Rezulin and the antidepressant, Zoloft were named. In…
Guardian Reports: MHRA to Issue New SSRI Restrictions Mon, 14 Jun 2004 The Guardian reports that the British Committee on safety and Medicines, which was first to issue warnings about the potential suicidal risk for children prescribed an antidepressant of the SSRI class, are now about to issue similar warnings…
Antidepressant Makers Withhold Data on Children – Washington Post Thu, 29 Jan 2004 A front page article in The Washington Post addresses the key issue undermining public health and safety. Drug companies conceal unfavorable clinical trial findings: the tests failed to demonstrate that antidepressants are either safe or beneficial for…
Comments re: Smallpox Vaccine Trial on 2-5 year old children Mon, 2 Dec 2002 Recent public and professional debate about a smallpox vaccine trial and its risks provides the framework for evaluating the ethical justification for conducting clinical trials on children. The Alliance for Human Research Protection has submitted documented…
NY Times Whitewashes Ritalin Experiment in Preschool Kids Sat, 16 Nov 2002 A story in The New York Times magazine about a controversial government sponsored drug experiment avoids examining the tough issues. Instead, it describes the growing pains of an apparently normal 4 year old boy, Sam, whose parents enrolled…
August 20, 2001 A landmark decision by Maryland’s highest court, the Court of Appeals of Maryland, is a victory for the human rights of children. The decision affirms the responsibility of parents, the government, researchers and institutional review boards (IRB) to protect children from non-therapeutic experiments that may put their health…
Court Strikes Down FDA Pediatric Rule Fri, 18 Oct 2002 Court ruling posted at: http://www.dcd.uscourts.gov/00-02898.pdf FDA’s pediatric Rule has been struck down by a federal District Court. The Court ruling came at the exact time that AHRP disseminated an Infomail explaining why AHRP is opposed to the exploitation of children…
Drug Testing Debate – Parenting Mag 4 Pt. Series Tue, 22 Oct 2002 Parenting Magazine published a 5-part report about the impact on children of FDA’s “The Pediatric Rule.” That Rule provides drug companies six month patent extension on drugs tested in children. This financial windfall could translate into some…
